| Ontology | CARD's Antibiotic Resistance Ontology | 
| Accession | ARO:3000269 | 
| Definition | Brodimoprim is a structural derivative of trimethoprim and an inhibitor of bacterial dihydrofolate reductase. The 4-methoxy group of trimethoprim is replaced with a bromine atom. | 
| SMILES | COc1cc(Cc2cnc(N)nc2N)cc(OC)c1Br | 
| PubChem | 68760 | 
| ChEMBL | CHEMBL31891 | 
| CAS | 56518-41-3 | 
| ChEBI | 131726 | 
| Drug Class | diaminopyrimidine antibiotic | 
| Classification | 2 ontology terms | Show | 
| Parent Term(s) | 1 ontology terms  | Show + diaminopyrimidine antibiotic [Drug Class] | 
| Sub-Term(s) | 1 ontology terms  | Show + antibiotic sensitive dihydrofolate reductase  targeted_by_antibiotic | 
| Publications | Morgan WD, et al. 1999. Biochemistry 38(7): 2127-2134. 1H/15N HSQC NMR studies of ligand carboxylate group interactions with arginine residues in complexes of brodimoprim analogues and Lactobacillus casei dihydrofolate reductase. (PMID 10026296) Thomson CJ. 1993. J Chemother 5(6): 458-464. Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria. (PMID 8195838) Periti P. 1995. J Chemother 7(3): 221-223. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview. (PMID 7562018) | 
| Curator | Description | Most Recent Edit | 
|---|